The global biomedical warming and thawing devices market revenue was around US$ 173.7 million in 2022 and is estimated to reach US$ 380.3 million by 2031, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2031.
Biomedical warming and thawing devices are utilized to defrost samples of tissues, blood, cells, and other biologics. Tissues and cells can be successfully and reliably preserved utilizing cryopreservation at lower temperatures, frequently below freezing. Thus, these biological products must be defrosted before to utilized. In this situation, biomedical warming and thawing devices are important since they assist with the warming and defrosting of cryopreserved products.
Market Driving Factors
Raising demand for biopharmaceuticals is predicted to dominate the market growth. This is primarily due to the developing call for biopharmaceutical merchandise, such as antibodies, vaccines, and mobile-primarily based cures, which has pushed the requirement for green and special warming and thawing devices. As a result, these devices are necessary for secure and effective garage and biopharmaceutical processing.
Advances in biobanking and bio-preservation are predicted to drive the market expansion. This is because bio-preservation and biobank centers are critical for the storage of biological tissues, samples, and cells for studies and medical procedures. As a result, the adoption of automatic warming and thawing devices in these facilities has doubled owing to their ability to thaw samples rapidly even while maintaining their integrity.
The high initial financial investment needed for those devices may be a big obstacle, especially for research laboratories, smaller healthcare facilities, and developing countries. Thus, this factor hampers the market.
Regional Analysis
North America dominated the market in terms of revenue and is expected to maintain its dominance. This can be greatly attributed to the high existence of the biomedical industry manufacturing biomedical warming and thawing devices and technological advances in the healthcare sector.
Asia-Pacific dominates the market in terms of the fastest growth rate. This is primarily due to the surge in the activity of blood donation, and the increase in the number of blood transfusion centers and blood banks. Additionally, the surge in expenses by the government to create the healthcare sector is driving the market growth.
Segmentation Insights
Product Insight
The automatic segment is estimated to dominate the market in terms of the largest shares. This is because surge in the usage of automatic warming and thawing devices for storage of cryopreserved products and the effectiveness of devices to reserve them.
Sample Type Insight
The stem cell segment dominates the market in terms of revenue. This is mainly due to the growth in the utilization of stem cells for research and treatment purposes, technological advances in cell therapy, and a boost in R&D activities.
The blood products segment dominated the market in terms of the rate and continues its dominance. This is primarily owing to the rise in blood donation activity, increase in the prevalence of blood diseases, and rise in the number of blood banks.
End User Insight
The hospitals & diagnostic laboratories segment is predicted to dominate the market in terms of the shares. This is mainly due to the surge in the number of hospitals & diagnostic laboratories and the rising initiative taken by the government to create healthcare infrastructure.
The blood banks & stem cell banks segment dominates the market in terms of the growth rate. This growth is due to the surge in the number of blood banks & stem cell banks, an increase in R&D activities, a rise in blood donation activity, and a boost in demand for cryopreserved blood products.
Prominent Companies
Segmentation Outline
The global biomedical warming and thawing devices market segmentation focuses on Product, Sample Type, End User, and Region.
By Product
By Sample Type
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: BIOMEDICAL WARMING AND THAWING DEVICES MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 MANUAL
5.3 AUTOMATIC
6 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY SAMPLE TYPE
6.1 OVERVIEW
6.2 BLOOD PRODUCT
6.2.1 PLASMA
6.2.2 RBC
6.3 STEM CELL
6.4 EMBRYO
6.5 OVUM
6.6 OTHERS
7 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
7.3 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.4 BLOOD BANKS AND STEM CELL BANKS
8 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 SARSTEDT AG AND CO. KG
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 FISHER SCIENTIFIC PTE LTD
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 CYTIVA
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 SARTORIUS AG
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 EPPENDORF
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 GENERAL ELECTRIC COMPANY
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 FREMON SCIENTIFIC INC.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 FARRAR SCIENTIFIC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 THAWWORLD MEDICAL LTD.
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 BIOLIFE SOLUTIONS
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 CONROY MEDICAL AB
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 BARKEY GMBH AND CO. KG
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 HELMER SCIENTIFIC
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 KW APPARECCHI SCIENTIFICI
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 CARDINAL HEALTH
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 CYTOTHERM
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 BOEKEL SCIENTIFIC
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved